IVA News and Press, Inventiva S.A. From 10/27/23

2023-10-27 15:00:00 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week, or the Seeking Alpha earnings calendar ...

2023-09-29 14:58:08 ET Inventiva S.A. (IVA) Q2 2023 Earnings Analyst Conference Call September 29, 2023, 08:00 AM ET Company Participants Frederic Cren - CEO Jean Volatier - CFO Michael Cooreman - Chief Medical Officer Conference Call Participants Ed ...

2023-09-28 16:28:45 ET More on Inventiva Inventiva: An Untenable Cash Position Despite Enviable Data Inventiva and Hepalys Pharma to develop and commercialize Lanifibranor in Japan and South Korea Inventiva announced €35.7M funding, eyes future raise to meet o...

Novonix Limited (NVNXF) is expected to report for quarter end 2023-06-30 LifeWorks Inc (MSIXF) is expected to report for quarter end 2023-06-30 Arrival (ARVL) is expected to report for quarter end 2023-06-30 Treasure Global Inc. (TGL) is expected to report $-0.16 for Q4 2023 Manch...

2023-09-21 01:42:37 ET More on Inventiva Seeking Alpha’s Quant Rating on Inventiva Historical earnings data for Inventiva Financial information for Inventiva Inventiva: An Untenable Cash Position Despite Enviable Data Inventiva announced Ȋ...

2023-08-31 13:06:38 ET More on Inventiva Inventiva: An Untenable Cash Position Despite Enviable Data Inventiva jumps 25% after mid-stage data for NASH candidate Inventiva GAAP EPS of -€1.31 misses by €0.02, revenue of €12.18M misses by €0....

2023-08-14 13:19:20 ET Despite recent setbacks, drugmakers are still forging ahead in their quest to develop effective treatments for non-alcoholic steatohepatitis, or NASH, a growing public health concern that could represent a roughly $108B global market opportunity by 2030. According...

2023-07-16 09:01:42 ET Summary IVA has robust data from a mid-stage NASH trial. They have an ongoing pivotal study running, to topline in H2 2025. They don't have enough cash to complete that trial. Inventiva ( IVA ) is a small French company developing medicines...

2023-06-27 13:03:37 ET Biopharmaceutical firms focused on liver diseases trended lower Tuesday after pharma giant Eli Lilly ( NYSE: LLY ) announced data highlighting the potential of its weight loss candidate retatrutide in obese patients with excess liver fat. The condition kno...

2023-06-15 08:21:52 ET Leju Holdings  ( LEJU ) +40% . CBAK Energy Technology ( CBAT ) +26% Received Order From Viessmann Group for EUR116.5 Million of Lithium-Ion Batteries for 2024. BitNile Metaverse ( BNMV ) +24% . Applied UV ( AUVI ) +20% ...